Reconnect Labs is a Swiss-based, clinical stage biopharmaceutical company on a mission disrupt the cycle of illness that underlies mental health conditions.

Leveraging decades of expertise and a world-class network of leaders in clinical drug development, Reconnect Labs is progressing the development of rapid-acting, short duration, precision neuropsychiatry designed drug candidates with the potential to transform the treatment landscape for sleep, anxiety and substance use disorders.

With our innovative approach to the design of precision therapeutics, and use of digital psychiatry tools as precision diagnostics, we are  aim to deliver commercially scalable and accessible treatments that will provide both immediate symptom alleviation and durable, long-term, disease modifying therapeutic benefits.


Health Care

Life Sciences

Therapeutics

Reconnect Labs

Reconnect Labs' headquarters in Zurich, Switzerland

Description

People (6)

Davor Kosanic

Daniel Claussen

Nicholas Draeger

Dario-Alessandro Dornbierer

Robin von Rotz

Jennifer Ross-Jones

Jobs